University of Hamburg

About: University of Hamburg is a education organization based out in Hamburg, Germany. It is known for research contribution in the topics: Population & Laser. The organization has 45564 authors who have published 89286 publications receiving 2850161 citations. The organization is also known as: Hamburg University.

Tunable Gauge Potential for Neutral and Spinless Particles in Driven Optical Lattices

Abstract: We present a universal method to create a tunable, artificial vector gauge potential for neutral particles trapped in an optical lattice. The necessary Peierls phase of the hopping parameters between neighboring lattice sites is generated by applying a suitable periodic inertial force such that the method does not rely on any internal structure of the particles. We experimentally demonstrate the realization of such artificial potentials, which generate ground-state superfluids at arbitrary nonzero quasimomentum. We furthermore investigate possible implementations of this scheme to create tunable magnetic fluxes, going towards model systems for strong-field physics.

The placebo response in medicine: minimize, maximize or personalize?

Abstract: The therapeutic outcome of a drug or procedure is influenced by the placebo response in both drug development and clinical practice. Enck and colleagues examine how the placebo response can be utilized in these settings to ensure that the most desirable outcome is attained. Our understanding of the mechanisms mediating or moderating the placebo response to medicines has grown substantially over the past decade and offers the opportunity to capitalize on its benefits in future drug development as well as in clinical practice. In this article, we discuss three strategies that could be used to modulate the placebo response, depending on which stage of the drug development process they are applied. In clinical trials the placebo effect should be minimized to optimize drug–placebo differences, thus ensuring that the efficacy of the investigational drug can be truly evaluated. Once the drug is approved and in clinical use, placebo effects should be maximized by harnessing patients' expectations and learning mechanisms to improve treatment outcomes. Finally, personalizing placebo responses — which involves considering an individual's genetic predisposition, personality, past medical history and treatment experience — could also maximize therapeutic outcomes.

Shape similarity measure based on correspondence of visual parts

Abstract: A cognitively motivated similarity measure is presented and its properties are analyzed with respect to retrieval of similar objects in image databases of silhouettes of 2D objects. To reduce influence of digitization noise, as well as segmentation errors, the shapes are simplified by a novel process of digital curve evolution. To compute our similarity measure, we first establish the best possible correspondence of visual parts (without explicitly computing the visual parts). Then, the similarity between corresponding parts is computed and aggregated. We applied our similarity measure to shape matching of object contours in various image databases and compared it to well-known approaches in the literature. The experimental results justify that our shape matching procedure gives an intuitive shape correspondence and is stable with respect to noise distortions.

Nucleotide sequence of cloned cDNA encoding bovine arginine vasopressin-neurophysin II precursor.

Abstract: The sequence of a cDNA encoding the nonapeptide arginine vasopressin (A VP) and its carrier protein, neurophysin II (NpII) from bovine hypothalamus, proves that the 166-amino acid precursor molecule contains a signal peptide of 19 amino acids followed directly by A VP connected to NpII by a Gly-Lys-Arg sequence. The carboxy-terminal region of the precursor contains a naturally occurring glycopolypeptide of 39 amino acids which is separated from NpII by a single arginine residue.